Cargando…
The clinical utility of circulating cell division control 42 in small-vessel coronary artery disease patients undergoing drug-coated balloon treatment
BACKGROUND: Cell division control 42 (CDC42) regulates atherosclerosis, blood lipids, and inflammation and thus affects coronary artery disease (CAD), but its utility in drug-coated balloon (DCB)-treated small-vessel CAD (SV-CAD) patients is unclear. This study intended to evaluate the change and pr...
Autores principales: | Wu, Lei, Li, Hui, Chen, Huanzhen, Fan, Chunyu, Lu, Yan, Wei, Ruipeng, Yang, Guangzhao, Jia, Yongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559608/ https://www.ncbi.nlm.nih.gov/pubmed/37805479 http://dx.doi.org/10.1186/s12872-023-03476-5 |
Ejemplares similares
-
Meta-analysis of the effects of drug-coated balloons among patients with small-vessel coronary artery disease
por: Yang, Jing-qi, et al.
Publicado: (2019) -
Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review
por: Nestelberger, Thomas, et al.
Publicado: (2019) -
Drug-coated balloon: an effective alternative to stent strategy in small-vessel coronary artery disease—a meta-analysis
por: Felbel, Dominik, et al.
Publicado: (2023) -
Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels
por: Rosenberg, Mark, et al.
Publicado: (2019) -
Resveratrol-Coated Balloon Catheters in Porcine Coronary and Peripheral Arteries
por: Kamann, Stefanie, et al.
Publicado: (2019)